mRNA |
BRD-K58730230 |
CTRPv2 |
pan-cancer |
AAC |
0.002 |
1 |
mRNA |
tigecycline |
CTRPv2 |
pan-cancer |
AAC |
0.0012 |
1 |
mRNA |
SB-225002 |
CTRPv2 |
pan-cancer |
AAC |
-0.00075 |
1 |
mRNA |
doxorubicin:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.00073 |
1 |
mRNA |
temsirolimus |
CTRPv2 |
pan-cancer |
AAC |
0.001 |
1 |
mRNA |
S-Trityl-L-cysteine |
GDSC1000 |
pan-cancer |
AAC |
0.001 |
1 |
mRNA |
Cetuximab |
GDSC1000 |
pan-cancer |
AAC |
0.00065 |
1 |
mRNA |
BRD-K03536150 |
CTRPv2 |
pan-cancer |
AAC |
-0.00073 |
1 |
mRNA |
carboplatin:etoposide (40:17 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.00052 |
1 |
mRNA |
ML162 |
CTRPv2 |
pan-cancer |
AAC |
0.00039 |
1 |